HOME >> BIOLOGY >> NEWS
2006 World Food Prize recipients to be recognized at soils congress

ocked Brazil's tremendous potential for food production. Their pioneering advancements made agricultural development possible in the Cerrado."

Dr. McClung's pioneering soil fertility research in the 1950s analyzed the complexity of Cerrado soils and showed that a transformation of the region was possible. His work uncovered an innovative soil improvement process to correct the drastic nutrient depletion of the Cerrado and counteract aluminum toxicity in the region's highly acidic soils, concluding that the Cerrado could be made suitable for production of crops as diverse as coffee, soybeans, citrus and corn.

Beginning his career as Secretary of Agriculture in the state of Minas Gerais in the early 1970s, Alysson Paolinelli created a new model for rural credit and other development programs. He envisioned and oversaw the creation of the institutional and financial infrastructure that enabled crop and livestock production to flourish in the Cerrado. As Minister of Agriculture from 1974 to 1979, he was instrumental in establishing the Brazilian Agricultural Research Corporation (EMBRAPA) to provide a system of technical, administrative and research support to farmers and agribusinesses.

Edson Lobato was a leader in evaluating and carrying out studies of Cerrado soil fertility and agricultural production. During the course of his 30-year career as an agronomy engineer and administrator at EMBRAPA, Lobato led Cerrado soil fertility and agronomy research as it expanded to include soil microbiology, soil management, and crop management.


'"/>

Contact: Sara Uttech
suttech@soils.org
608-268-4948
American Society of Agronomy
23-Jun-2006


Page: 1 2

Related biology news :

1. World Wildlife Fund warns against iron dumping experiment near the Galapagos Islands
2. Worlds first X-ray free electron laser is on course to completion
3. Worlds leading scientists announce creation of Encyclopedia of Life
4. Prize winners announced at ISNs World Congress of Nephrology
5. World first test potential to identify breast cancer patients who will react badly to radiotherapy
6. Worlds top engineers in San Antonio for system of systems conference
7. OneWorld Health selects Odyssey Research for phase 4 study in India
8. MicrobeWorld podcast wins another award
9. International Astronautical Federation joins project to protect World Heritage sites
10. Press registration -- World Congress of Nephrology, April 21-25, 2007, Rio de Janeiro, Brazil
11. Nature Genetics and the International Society of Nephrology come to Danvers on World Kidney Day

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: World Food Prize recipients recognized soils congress

(Date:7/13/2015)... OXFORD, Conn. , Jul. 13, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... it has filed provisional patent 62/188684 for ... NXT-ID achieves another new convenient and secure method ... expands new, innovative payment methods, introduced with its ...
(Date:7/9/2015)... July 9, 2015  Unchained Labs just can,t ... acquisition of Avid Nano. Avid Nano designs, develops ... systems.    Also today, Unchained Labs ... easiest to use protein sizing system. The pUNk ... protein,s hydrodynamic size, size distribution, aggregation population and ...
(Date:7/8/2015)... LAKES , N.J. and NEW YORK ... Company) and Guidepoint today announced BD ... start-up healthcare companies with free access to Guidepoint,s expert ... several start-ups that are developing cutting-edge technologies to improve ... a dedicated Guidepoint research manager, each start-up entrepreneur will ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
(Date:7/30/2015)... Ascendis Pharma A/S (Nasdaq: ASND ... TransCon technology to address significant unmet medical needs, ... Phase 2 study to evaluate the safety and ... treatment-naïve, pre-pubertal children with growth hormone deficiency, or ... the top-line results from our Phase 2 pediatric ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... advanced fluid applications and designed for continuous operation up to 1500 bar. The ... ensuring safety, efficiency, and preventing toxic contamination. , The Pony™ NS2006L homogenizer is ...
(Date:7/29/2015)... 29, 2015 US-Australian drug discovery company, Novogen ... it is committed to progressing its ground-breaking technology platforms ... and to ensure the Company delivers the best value ... Iain Ross , said the Company currently had an ... programs, discovery programs and academic partnerships and initiatives, and ...
(Date:7/29/2015)... FRANCISCO , July 29, 2015  AsureQuality ... mobile molecular testing for applications in food and ... hand-held, battery powered real-time PCR device, the Freedom4. ... farm right through to the supermarket shelf for ... This includes involvement in animal disease control and ...
Breaking Biology Technology:Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2
Cached News: